Regulatorische Updates
28. Sept. 2026•1 Min. Lesezeit
FDA Discontinues Hydrocortisone 0.5% Ointment (ANDA084969)
The FDA has listed the hydrocortisone 0.5% topical ointment (product 003) from Perrigo New York as discontinued under application ANDA084969.
Regulatorische Updates
25. Sept. 2026•1 Min. Lesezeit
FDA Approves ANDA078547 for Nicotine Polacrilex OTC Chewing Gum
The FDA has approved ANDA078547 for a 2 mg nicotine polacrilex chewing gum, an over‑the‑counter nicotine replacement product marketed under several brand names.
Regulatorische Updates
30. Aug. 2026•1 Min. Lesezeit
FDA ANDA083061: Diphenhydramine Hydrochloride Capsules Discontinued
FDA ANDA083061 lists two oral diphenhydramine hydrochloride capsule products (25 mg and 50 mg) from Perrigo, both marked discontinued.